Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael S. Fleming
Michael S. Fleming
ImmunoGen, Inc.
Conjugate
Chemistry
Drug
Antibody
Maytansinoid
4
Papers
41
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An Intercompany Perspective on Biopharmaceutical Drug Product Robustness Studies
2018
Journal of Pharmaceutical Sciences
Sorina Morar-Mitrica
Monica L. Adams
George Crotts
Christine Wurth
Peter M. Ihnat
Tanvir Tabish
Valentyn Antochshuk
Willow Diluzio
Daniel Dix
Jason E. Fernandez
Kapil Gupta
Michael S. Fleming
Bing He
James K. Kranz
Dingjiang Liu
Chakravarthy Narasimhan
Eric Routhier
Katherine Taylor
Nobel T. Truong
Elaine S.E. Stokes
Show All
Source
Cite
Save
Citations (4)
Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates
2016
mAbs
Kalli C. Catcott
Molly A. McShea
Carl Uli Bialucha
Kathy Miller
Stuart W. Hicks
Parmita Saxena
Thomas G. Gesner
Mikias Woldegiorgis
Megan E. Lewis
Chen Bai
Michael S. Fleming
Seth Ettenberg
Hans K. Erickson
Nicholas C. Yoder
Show All
Source
Cite
Save
Citations (17)
Abstract 5442: Microscale methods for preparation and screening of antibody-drug conjugates
2015
Cancer Research
Nicholas C. Yoder
Kalli C. Catcott
Molly A. McShea
Carl Uli Bialucha
Parmita Saxena
Chen Bai
Kathy Miller
Thomas G. Gesner
Mikias Woldegiorgis
Stuart W. Hicks
Megan E. Lewis
Michael S. Fleming
Hans K. Erickson
Seth E. Ettenberg
Thomas A. Keating
Show All
Source
Cite
Save
Citations (0)
A reversed-phase high-performance liquid chromatography method for analysis of monoclonal antibody-maytansinoid immunoconjugates
2005
Analytical Biochemistry
Michael S. Fleming
Wei Zhang
John M. Lambert
Godfrey W. Amphlett
Show All
Source
Cite
Save
Citations (20)
1